Brimo 0.15% Eye Drop is used in the treatment of ocular hypertension (pressure in the eye) and glaucoma. It helps to lower high pressure in the eye and reduces the risk of vision loss. This medicine may be used alone or in combination with another eye drop that reduces pressure in the eye.

Brimo 0.15% Eye Drop is to treat increased pressure inside the eye

Uses of Brimo Eye Drop

Ocular hypertension

Benefits of Brimo Eye Drop

In Ocular hypertension

Ocular hypertension is a condition where the pressure inside the eye is higher than normal eye pressure. This may occur due to an injury, certain diseases or as an adverse effect of certain medications. Brimo 0.15% Eye Drop reduces the fluid accumulation of the eye and facilitates draining of the fluid from the eyes. This helps treat ocular hypertension and prevents further damage or complications such as vision changes or even vision loss.

Side effects of Brimo Eye Drop

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Brimo

Eye itching
Allergic reaction in eye
Conjunctival hyperemia
Follicular conjunctivitis
Dryness in mouth
Allergic conjunctivitis
Burning sensation
High blood pressure

How to use Brimo Eye Drop

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Safety advice

Alcohol

No interaction found/established

Pregnancy

SAFE IF PRESCRIBED

Brimo 0.15% Eye Drop is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

SAFE IF PRESCRIBED

Brimo 0.15% Eye Drop is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
To reduce the amount of Brimo 0.15% Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

Driving

UNSAFE

Brimo 0.15% Eye Drop may cause side effects which could affect your ability to drive.
Brimo 0.15% Eye Drop may cause blurred or abnormal vision. This effect may seem worse at night or in reduced lighting and this may affect the ability to drive.

Kidney

No interaction found/established

Liver

No interaction found/established

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Brimo 0.15% Eye Drop

₹285.0/Eye Drop

Alcon Brimo Eye Drop

Alcon Laboratories

₹285/eye drop

same price

Brimochek Eye Drop

Indoco Remedies Ltd

₹275/eye drop

4% cheaper

Rimonid 0.15% Eye Drop

Micro Labs Ltd

₹160/eye drop

44% cheaper

Globrim 0.15% Eye Drop

Torrent Pharmaceuticals Ltd

₹120/eye drop

58% cheaper

Rimoflo Eye Drop

Ipca Laboratories Ltd

₹205/eye drop

28% cheaper

Quick tips

Brimo 0.15% Eye Drop helps lower high pressure in the eye and reduces the risk of vision loss.
For best results, put one drop 2-3 times daily in the affected eye(s).
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
Remove contact lenses before using Brimo 0.15% Eye Drop and allow at least 15 minutes before re-inserting them.
Do not touch the tip of the dropper to any surface, or to your eye, to avoid contaminating the eye drops.
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
It may cause short term blurring of vision when first used. Use caution before driving or using machines.
It may cause temporary burning or itching sensation in the eye. Inform your doctor if this does not go away.
Make sure to use within 4 weeks of opening the bottle.

Fact Box

Chemical Class

Quinoxaline Derivative

Habit Forming

Therapeutic Class

OPHTHAL

Action Class

Sympathomimetics- Ocular

Patient concerns

Doctor advised for medication for glaucoma suspect only because eye pressure is 22 but all other tests are normal.medicine , 9 pm drops is prescribed. Please advice

Dr. Vishal Arora

Ophthalmology

Ocular hypertension can lead to glaucoma eventually. Continue the drops

Having visual ocular migrane atleast twice a week please recommend the right medicine.

Dr. Vishal Arora

Ophthalmology

Get your detailed eye check up done

Top Ophthalmologists

Dr. Sanjay Verma

MBBS, MS

5 ★

Dr. Parul Sharma

MBBS, MS, DNB, Fellowship

4.2 ★

4.2 ★

4.5 ★

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 297.
Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 144.
Brimonidine tartrate. Fareham, Hampshire: FDC International Ltd.; 2010 [revised 24 Jun. 2014]. [Accessed 25 Jan. 2019] (online) Available from:
Brimonidine. Irvine, California: Allergan, Inc.; 1996 [revised May 2010]. [Accessed 04 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:

Marketer details

Name: Alcon Laboratories

Address: 54/1, Boodhihal, Nelamangala, Bangalore, -562123, Karnataka, India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.